Axios on MSN
Longevity medicine's do-or-die moment
The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...
IFLScience on MSN
World first trial to reprogram broken cells in glaucoma begins in humans – but is it just hype?
What would you give to be young again? For many, it’s the ultimate dream – one which, with an exciting and controversial new ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype ...
The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...
Pluristyx, a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, today announced the Japanese Patent Office (JPO) issued a ...
A new way of reprogramming our immune cells to shrink or kill off cancer cells has been shown to work in the otherwise hard to treat and devastating skin cancer, melanoma. The University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results